Seagen Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 12, 2010

Attached files

file filename
10-K - FORM 10-K - Seagen Inc.d10k.htm
EX-31.1 - SECTION 302 CERTIFICATION - Seagen Inc.dex311.htm
EX-32.2 - SECTION 906 CERTIFICATION - Seagen Inc.dex322.htm
EX-32.1 - SECTION 906 CERTIFICATION - Seagen Inc.dex321.htm
EX-31.2 - SECTION 302 CERTIFICATION - Seagen Inc.dex312.htm
EX-10.44 - EMPLOYMENT AGREEEMENT - Seagen Inc.dex1044.htm
EX-10.49 - AMENDMENT TO THE COLLABORATION AND LICENSE AGREEMENT - Seagen Inc.dex1049.htm
EX-10.50 - COLLABORATION AGREEMENT - Seagen Inc.dex1050.htm
EX-10.48 - COMPENSATION INFORMATION FOR EXECUTIVE OFFICERS AND DIRECTORS - Seagen Inc.dex1048.htm
EX-10.43 - EMPLOYMENT AGREEMENT - Seagen Inc.dex1043.htm
EX-10.13 - 2000 DIRECTORS' STOCK OPTION PLAN - Seagen Inc.dex1013.htm
EX-10.51 - LONG TERM INCENTIVE PLAN - Seagen Inc.dex1051.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-56670 and 333-148188) of Seattle Genetics, Inc., and in the Registration Statement on Form S-3 (File No. 333-159457) of Seattle Genetics, Inc. and in the related Prospectus, of our report dated March 11, 2010 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP

Seattle, Washington

March 11, 2010

Seagen Inc. Reports